Group One Trading
RYTM icon

Group One Trading’s Rhythm Pharmaceuticals RYTM Stock Holding History

Group One Trading’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$983K Sell
11,300
-28,800
-72% -$2.8M ﹤0.01% 2738
2025
Q4 		$4.29M Buy
40,100
+39,500
+6,583% +$4.19M 0.01% 1644
2025
Q3 		$60.6K Buy
600
+300
+100% +$27.9K ﹤0.01% 5788
2025
Q2 		$19K Sell
300
-3,800
-93% -$233K ﹤0.01% 6294
2025
Q1 		$217K Sell
4,100
-26,100
-86% -$1.45M ﹤0.01% 3939
2024
Q4 		$1.69M Sell
30,200
-15,400
-34% -$851K ﹤0.01% 2071
2024
Q3 		$2.39M Buy
45,600
+31,600
+226% +$1.51M 0.01% 1587
2024
Q2 		$575K Buy
14,000
+13,800
+6,900% +$551K ﹤0.01% 2440
2024
Q1 		$8.67K Sell
200
-23,900
-99% -$1.05M ﹤0.01% 5943
2023
Q4 		$1.11M Sell
24,100
-49,000
-67% -$1.55M ﹤0.01% 2375
2023
Q3 		$1.68M Sell
73,100
-43,900
-38% -$983K 0.01% 1792
2023
Q2 		$1.93M Buy
117,000
+46,800
+67% +$845K 0.01% 1739
2023
Q1 		$1.25M Buy
70,200
+44,000
+168% +$1.1M ﹤0.01% 1942
2022
Q4 		$763K Sell
26,200
-71,400
-73% -$1.83M ﹤0.01% 2655
2022
Q3 		$2.39M Buy
97,600
+22,200
+29% +$413K ﹤0.01% 1762
2022
Q2 		$313K Buy
75,400
+11,600
+18% +$63.5K ﹤0.01% 3880
2022
Q1 		$735K Buy
63,800
+63,300
+12,660% +$556K ﹤0.01% 3405
2021
Q4 		$5K Buy
500
+300
+150% +$3.37K ﹤0.01% 7648
2021
Q3 		$3K Sell
200
-2,100
-91% -$32.1K ﹤0.01% 7884
2021
Q2 		$45K Sell
2,300
-18,800
-89% -$390K ﹤0.01% 6684
2021
Q1 		$449K Sell
21,100
-100
-0.5% -$2.9K ﹤0.01% 4175
2020
Q4 		$630K Buy
21,200
+14,000
+194% +$356K ﹤0.01% 3069
2020
Q3 		$156K Buy
+7,200
New +$165K ﹤0.01% 3851

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Group One Trading's RYTM Position: Q3 2024 in Review

Group One Trading sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2024, closing a stake of 4,991 shares — an estimated $239K sold.

Group One Trading first reported a position in RYTM in Q3 2020 and held it in 8 quarters. The position peaked at $205K in Q2 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • Group One Trading reported no remaining Rhythm Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 4,991 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $239K.
  • Group One Trading first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 8 quarters.
  • Group One Trading's Rhythm Pharmaceuticals position peaked at $205K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.